University of Otago PhD candidate Tiffany Ilott has received the 2026 Zonta Women in STEM Award for her innovative work developing three-dimensional cell models to study endometrial cancer. The US$10,000 global award recognises her contributions to advancing understanding of this common gynaecological malignancy through laboratory techniques that better replicate human tissue environments.

Recognising Excellence in New Zealand University Research

Ilott, a final-year doctoral researcher based at the University of Otago’s Christchurch campus, works within the Mackenzie Cancer Research Group. Her project focuses on endometrial cancer risk factors and disease mechanisms using advanced co-culture systems. These models allow scientists to observe interactions between cancer cells and surrounding stromal tissues in a controlled setting that more closely mirrors conditions inside the body than traditional two-dimensional cultures.

The award from Zonta International highlights the growing strength of postgraduate research programmes at New Zealand universities. Otago’s Department of Pathology and Biomedical Science provides the infrastructure and supervision that enable such specialised investigations. Supervisors including Dr Elisabeth Phillips guide candidates through complex experimental design, data analysis, and publication processes essential for translating laboratory findings into clinical insights.

Understanding Endometrial Cancer and Its Relevance in New Zealand

Endometrial cancer originates in the lining of the uterus and ranks as the most frequent gynaecological cancer among women in many developed countries, including New Zealand. Incidence rates have risen steadily over recent decades, influenced by factors such as obesity, later childbearing, and longer life expectancy. Early detection remains critical because five-year survival exceeds 80 percent when the disease is identified at stage one, yet outcomes decline sharply for advanced cases.

University-based researchers play a central role in addressing these challenges. Otago’s Christchurch location positions the team to collaborate with local health services, access diverse patient samples through ethical frameworks, and contribute to national cancer registries. This integration of academic inquiry with clinical practice strengthens the pipeline from bench to bedside that characterises effective higher-education research environments.

The Mechanics of 3D Cell Co-Culture Models

Traditional flat petri-dish cultures often fail to capture the spatial organisation and cell-to-cell signalling that occur in living organs. Ilott’s approach grows endometrial cancer cells alongside fibroblasts and immune cells in three-dimensional scaffolds. These scaffolds provide structural support and biochemical cues that encourage cells to form more realistic architectures, including glandular structures and stromal compartments.

By manipulating variables such as hormone exposure or genetic alterations within the models, researchers can test hypotheses about disease progression in a repeatable, ethically responsible manner. The technique reduces reliance on animal models while generating data that informs subsequent human studies. Otago’s laboratories supply the specialised equipment, including bioreactors and imaging systems, required for maintaining these delicate cultures over extended periods.

Photo by Roland Hechanova on Unsplash

Zonta International’s Commitment to Women in STEM

Zonta International, a global service organisation focused on empowering women, established the Women in STEM Award to support emerging female researchers. Recipients receive funding that assists with conference attendance, specialised training, or equipment purchases, thereby accelerating career trajectories. The 2026 cohort includes scholars from multiple countries, underscoring the organisation’s international reach and its particular emphasis on regions where women remain underrepresented in technical fields.

In New Zealand, Zonta clubs have long partnered with universities to promote gender equity. Past recipients from Otago and other institutions have gone on to secure postdoctoral positions, faculty roles, and leadership positions within research institutes. Ilott’s success continues this tradition, demonstrating how targeted philanthropic support complements government and university funding streams.

University of Otago’s Role in Advancing Biomedical Research

Founded in 1869, the University of Otago maintains a strong reputation for health sciences research. Its Christchurch campus hosts dedicated cancer laboratories that attract both domestic and international students. The institution’s strategic investments in postgraduate training, including scholarships and mentorship programmes, create pathways for talented individuals to pursue doctoral studies without financial barriers.

Otago’s collaborative culture encourages cross-disciplinary work between pathology, biomedical science, and clinical oncology departments. This environment proved instrumental for Ilott’s project, allowing access to expertise in molecular biology, histology, and biostatistics. Such institutional support directly contributes to New Zealand’s overall research output and its standing in global university rankings focused on life sciences.

Broader Implications for Women in New Zealand Higher Education

Women now constitute the majority of university enrolments in New Zealand, yet they remain less represented at senior academic levels and in certain STEM disciplines. Awards like the Zonta prize provide visible role models and practical resources that help address these imbalances. They also signal to prospective students that New Zealand universities actively nurture female talent in fields historically dominated by men.

Ilott’s achievement arrives at a time when the Tertiary Education Commission and Ministry of Business, Innovation and Employment emphasise diversity in research funding criteria. Universities respond by expanding targeted initiatives, from women-only scholarships to leadership development programmes. These efforts aim to retain skilled researchers within the country and enhance the quality of scientific inquiry through inclusive perspectives.

Future Directions for Endometrial Cancer Research at Otago

Building on her award-winning models, Ilott plans to investigate specific molecular pathways implicated in tumour invasion and metastasis. Future experiments may incorporate patient-derived cells to create personalised models that predict treatment responses. Such translational work aligns with national health priorities outlined by the Ministry of Health and could eventually influence screening protocols or therapeutic strategies.

Continued university investment in core facilities, such as advanced microscopy and bioinformatics support, will be essential. Partnerships with organisations like the Cancer Society of New Zealand and Health Research Council provide additional avenues for scaling promising findings. Otago’s track record of securing competitive grants positions it well to sustain momentum in this area.

Photo by Michael Darnall on Unsplash

Supporting the Next Generation of Researchers

PhD training at New Zealand universities extends beyond laboratory skills to include grant writing, science communication, and career planning. Otago offers workshops and one-on-one advising that prepare candidates for diverse post-doctoral paths, whether in academia, industry, or government agencies. Ilott’s recognition illustrates how these holistic programmes equip graduates to compete successfully on the international stage.

Prospective students considering biomedical research careers can explore opportunities through university websites and professional networks. Early engagement with supervisors, attendance at departmental seminars, and participation in student-led research groups all strengthen applications for competitive awards. The combination of rigorous training and external recognition creates a virtuous cycle that elevates institutional prestige.

Ilott’s Zonta Women in STEM Award underscores the vital contributions of University of Otago postgraduate researchers to pressing health challenges. Her work on endometrial cancer models exemplifies the innovative, patient-focused science emerging from New Zealand’s higher-education sector. As universities continue to prioritise equity, collaboration, and translational impact, stories like this one will multiply, strengthening both scientific discovery and the broader academic community.